CTI BioPharma Overview
Get informed when a big investor buys or sells
+ Follow27.83
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, CTIC shows a PEG ratio of 27.83. That is above the Healthcare sector average of 12.15. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 12.15. CTI BioPharma is at 27.83, which is higher that average. That is roughly 129.0% above the sector mean. Use the comparison chart on this page to see how CTIC stacks up against individual peers as well.
Investors watch CTIC's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. CTI BioPharma's latest reading is 27.83. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has CTI BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 27.83) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 12.15, while CTIC is at 27.83. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
